Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Localising the Seizure Onset Zone from Single-Pulse Electrical Stimulation Responses with a Transformer
J. C. Norris, Ajai Chari, Gerald Cooray, Martin Tisdall, Karl Friston, Richard Rosch (2024). Localising the Seizure Onset Zone from Single-Pulse Electrical Stimulation Responses with a Transformer. , DOI: https://doi.org/10.48550/arxiv.2403.20324.
Preprint299 days agoP13: CAN PATIENT-REPORTED OCULAR SYMPTOMS GUIDE DOSE MODIFICATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING BELANTAMAB MAFODOTIN?
Rakesh Popat, Ashraf Badros, Seema Kumar, Paula Rodríguez‐Otero, Alan R. Cohen, Salomon Manier, Peter M. Voorhees, Francesca Gay, Robert M. Rifkin, T. Martin, Ajai Chari, Katja Weisel, Asim V. Farooq, Bennie H. Jeng, Wee Joo Chng, H Lee, J. G. Berdeja, Vinay Jadhav, A Tosolini, L Eliason, A Palumbo, Meletios A Dimopoulos, Sagar Lonial, S. Trudel, PG Richardson, Evangelos Terpos (2022). P13: CAN PATIENT-REPORTED OCULAR SYMPTOMS GUIDE DOSE MODIFICATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING BELANTAMAB MAFODOTIN?. , 6, DOI: https://doi.org/10.1097/01.hs9.0000829624.40467.0d.
Article32 days agoEffects of Cytogenetic Risk on Outcomes in Multiple Myeloma Treated with Selinexor, Bortezomib, and Dexamethasone (XVd)
Nizar J. Bahlis, Shambavi Richard, Darrell White, Sebastian Grosicki, Christine Chen, Sosana Delimpasi, Heather J. Sutherland, Zvenyslava Maslyak, Michaël Sébag, Maria Gavriatopoulou, Suzanne Lentzsch, Ajai Chari, Maryana Simonova, Ivan Špıčka, Iryna Kriachok, Meletios A Dimopoulos, Halyna Pylypenko, Holger W. Auner, Xavier Leleu, Ganna Usenko, Roman Hájek, Reuben Benjamin, Tuphan Kanti Dolai, Dinesh Kumar Sinha, Christopher P. Venner, Mamta Garg, Don A. Stevens, Hang Quach, Sundar Jagannath, Philippe Moreau, Moshe Levy, Ashraf Badros, Larry D. Anderson, Thierry Façon, María‐Victoria Mateos, Michèle Cavo, Andrew DeCastro, Yi Chai, Dane R. Van Domelen, Moran Mishal, Ohad S. Bentur, Jatin J. Shah, Sharon Shacham, Michael Kauffman, Paul G. Richardson (2021). Effects of Cytogenetic Risk on Outcomes in Multiple Myeloma Treated with Selinexor, Bortezomib, and Dexamethasone (XVd). , 138(Supplement 1), DOI: https://doi.org/10.1182/blood-2021-146324.
Article32 days agoMM-040: Efficacy and Safety of Carfilzomib, Dexamethasone, Daratumumab (KdD) Twice-Weekly at 56 mg/m2 and Once-Weekly at 70 mg/m2 in Relapsed or Refractory Multiple Myeloma (RRMM): Cross-Study Comparison of the CANDOR and EQUULEUS studies
Xavier Leleu, Meral Beksaç, Takaaki Chou, Meletios A Dimopoulos, Sung‐Soo Yoon, H. Miles Prince, Luděk Pour, Tatiana Shelekhova, Ajai Chari, Monica Khurana, Mihaela Obreja, Ming Qi, Albert Oriol, David S. Siegel (2020). MM-040: Efficacy and Safety of Carfilzomib, Dexamethasone, Daratumumab (KdD) Twice-Weekly at 56 mg/m2 and Once-Weekly at 70 mg/m2 in Relapsed or Refractory Multiple Myeloma (RRMM): Cross-Study Comparison of the CANDOR and EQUULEUS studies. , 20, DOI: https://doi.org/10.1016/s2152-2650(20)30917-4.
Article32 days agoEFFICACY AND SAFETY OF CARFILZOMIB, DEXAMETHASONE, DARATUMUMAB TWICE-WEEKLY AT 56 MG/M2 AND ONCE-WEEKLY AT 70 MG/M2 IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: CROSS-STUDY COMPARISON OF CANDOR AND MMY1001
Xavier Leleu, Meral Beksaç, Takaaki Chou, Meletios A Dimopoulos, SS Yoon, H. Miles Prince, Ajai Chari, Albert Oriol, David S. Siegel, Monica Khurana, Ming Qi, Mihaela Obreja, Luděk Pour, Tatiana Shelekhova (2020). EFFICACY AND SAFETY OF CARFILZOMIB, DEXAMETHASONE, DARATUMUMAB TWICE-WEEKLY AT 56 MG/M2 AND ONCE-WEEKLY AT 70 MG/M2 IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: CROSS-STUDY COMPARISON OF CANDOR AND MMY1001. , 42, DOI: https://doi.org/10.1016/j.htct.2020.10.431.
Article32 days ago